CHRIS RALLIS - 14 Jun 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A Rallis
Issuer symbol
FENC
Transactions as of
14 Jun 2022
Transactions value $
$0
Form type
4
Filing time
16 Jun 2022, 09:26:31 UTC
Previous filing
08 Mar 2022
Next filing
18 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option (right to buy) Award $0 +20K $0.00 20K 14 Jun 2022 Common Shares 20K $5.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2022, Chris Rallis was granted a non-statutory stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.
F2 The option is 100% vested on the date of grant.